Dr. Garcia-Garcia is an advisor for the Working Group for Clinical Care of the National Plan of Preparation and Response to the Influenza Pandemic of the Secretariat of Health, the National Survey of Tuberculosis Drug Resistance of the Secretariat of Health and the Mexican section of the Committee Stop TB. She reviews articles from several journals such as PLOS, Diabetes Care, Tuberculosis, Clinical Infectious Diseases, among others.
Dr. Garcia-Garcia has been interested in research in infectious diseases particularly tuberculosis and vaccine preventable diseases. In 2015 she co-authored a book on Vaccines for the Ageing Population published by the Mexican Academy of Medicine.
She has published more than 100 research articles, 5 books, and 44 book chapters. She has taught several courses at postgraduate level and directed 23 Specialty, Masters and Doctoral theses at the National Institute of Public Health since 1995 to present.
Industry Expertise (1)
Areas of Expertise (4)
Featured Articles (4)
Aerosol measles vaccination has been found to be more immunogenic than subcutaneous administration as a booster in school aged children, and immunogenic in 12-month-old children as a primary dose. The objective of the study was to evaluate immunogenicity to aerosol measles vaccine in 9-month-old children.
Infants were immunized by aerosol (103.6 plaque-forming units [pfu]/dose) or subcutaneous (sc) (104.27 pfu/dose) administration of Edmonston-Zagreb measles vaccine. Measles-specific T cell proliferative responses with a stimulation index of ⩾3 developed in 72% of children given aerosol-administered vaccine, compared with 87% given sc-administered vaccine (P = .06)...
OBJECTIVE. To identify risk factors associated with tuberculin reactivity in healthcare workers (HCWs)...
A prospective cohort and molecular epidemiologic study was conducted in southern Mexico. Between March 1995 and February 1998 all patients with persistent cough whose sputa had acid-fast bacilli (AFB) underwent clinical and mycobacteriologic evaluation (species identification, drug susceptibility testing, and IS6110-based genotyping). Treatment was provided in accordance with Mexico's National Tuberculosis Program...